Back to Trials
NCT05839652PHASE4Recruiting

Treatment of Orthostatic Hypotension in SCI

James J. Peters Veterans Affairs Medical Center

Start Date

7/1/2023

Completion Date

6/30/2026

Summary

The purpose of this study is to identify the effects of non-pharmacological and pharmacological anti-hypotensive treatment interventions on orthostatic hemodynamic responses, symptoms of autonomic dysreflexia and orthostatic hypotension, and levels of fatigue and comfort in hypotensive individuals with SCI.

Eligibility Criteria

Age Range: 18 years to 60 years

Inclusion Criteria: * traumatic spinal cord injury * at least 12 months post injury * injury level of C1-T6 * AIS A, B or C * non-ambulatory * non-ventilator Exclusion Criteria: * Active psychiatric disorder * Stroke or cerebrovascular disease * Alzheimer's Disease or dementia * Unmanaged cardiac arrhythmias * Concurrent systemic, hepatic, or renal disease * Suspected or diagnosed malignancy * Neurological disease other than SCI * Self-reported history of three or more symptomatic episodes of AD per day

Interventions

DRUG

Midodrine Hydrochloride

Interested in This Trial?

Contact the trial locations directly using the information below to learn more about enrollment.

Expressing interest lets you review the study and consent before we connect you with the research site.

Conditions

Hypotension

Locations

Kessler Foundation

West Orange, New Jersey 07052

United States

James J Peters VA Medical Center

The Bronx, New York 10468

United States